Updating the chest pain algorithm: Incorporating new evidence

Critical Pathways in Cardiology

Volumn 7, Issue 4, 2008, Pages 211-222

  Goyal, Neil ^a   Stant, Jennifer ^a   Esposito, Francesca ^a   Piri, Gina ^a   Collins, Michael ^a   Sayan, Osman ^a   Neuberg, Gerald ^a   Miller, Leslie ^a   Moses, Jeffery W ^a   Stone, Gregg W ^a   Giglio, James ^a   Rabbani, Leroy E ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Clinical pathways

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CLOPIDOGREL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPLERENONE; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; MORPHINE; SPIRONOLACTONE; THIENOPYRIDINE DERIVATIVE; TROPONIN; VALSARTAN; WARFARIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ALGORITHM; BLEEDING; BLOOD CLOT LYSIS; CLINICAL PATHWAY; CLINICAL TRIAL; CONTINUOUS INFUSION; CORONARY STENT; DIET; DRUG MEGADOSE; ELECTROCARDIOGRAM; EMERGENCY WARD; EVIDENCE BASED MEDICINE; EXERCISE; HEART CATHETERIZATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; LIFESTYLE MODIFICATION; LOADING DRUG DOSE; MONOTHERAPY; MORTALITY; OXYGEN THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SECONDARY PREVENTION; SMOKING CESSATION; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS; VITAL SIGN; FEMALE; FIBRINOLYTIC THERAPY; FORECASTING; HEART MUSCLE REVASCULARIZATION; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STANDARD; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

ACUTE CORONARY SYNDROME; ALGORITHMS; ANGINA, UNSTABLE; CHEST PAIN; COMBINED MODALITY THERAPY; CRITICAL PATHWAYS; EVIDENCE-BASED MEDICINE; FEMALE; FORECASTING; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; UNITED STATES;

EID: 58249087352     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e31818e506b     Document Type: Review

References (18)

1. Biviano AB, Bergmann SR, Tenenbaum J, et al. Design of a comprehensive chest pain initiative in an academic urban hospital. Critic Pathw Cardiol. 2003;2:113-117.
2. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297: 1892-1900.
3. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 Guidelines for the management of patient with ST- elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing group to review new evidence and update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial infarction). Circulation. 2008;177:296-329.
4. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST- elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction). J AM Coll Cardiol. 2007;50:e1-e157.
5. Mehta SR, Yusuf S, Peters RJ, et al. Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreat- ment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-533.
6. Steinbuhl SR, Berger PB, Mann JT III, et al. CREDO investigators. Clopidogrel for the reduction of events during observation: early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420.
7. Sabatine MS, Cannon CP, Gibson CM, et al. CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189.
8. Sabatine MS, Cannon CP, Gibson CM, et al. CLARITY-TIMI 28 investigators. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics. The PCI CLARITY Study. JAMA. 2005; 294:1224-1232.
9. Muller I, Seyfarth M, Riidiger S, et al. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart. 2001;85:92-93.
10. Patti G, Colonna G, Pasceri V, et al. Randomized trial of high loading dose of clopidogrel for eduction of periprocedural myocardial infarction in patients undergoing coronary intervention results from the ARMYDA-2 Study. Circulation. 2005;111:2099-2106.
11. Cuisset T, Frere C, Quilici J, et al. Benefit of a 600 mg loading dose on clopidopgrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. J Am Coll Cardiol. 2006;48:1339-1345.
12. Hochholzer W, Trenk D, Frundi D, et al. Time dependence of platelet inhibition after a 600mh loading dose of clopidogrel in a large, uns- elected cohort of candidates for percutaneous coronary intervention. Circulation. 2005;111:2560-2564.
13. Von Beckerath N, Taubert D, Pogatsa-Murray G, et al. Absorption, metabolization, and antiplatelet effects of 300mg, 600mg, and 900mg loading doses of clopidogrel. Results of the ISAR-CHOICE trial. Circulation. 2005;112:2946-2950.
14. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl JMed. 2006;355:2203-2216.
15. Stone GW, Ware JH, Bertrand ME, et al. Antithrombotic strategies in patients with acute coronary yndromes undergoing early invasive management: one year results from the ACUITY trial. JAMA. 2007;298: 2497-2506.
16. White HD, Chew DP, Hoekstra JW, et al. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivaliru- din in patients with non ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. JAm Coll Cardiol. 2008;51:1734-1741.
17. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218 -2230.
18. Dangas GD, Guagliumi G, Witzenbichler B, et al. Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction: The HORIZONS AMI trial. Presented at: ACC 2008. Available at: http:// www.TCTMD.com. Accessed April 12, 2008.